Introduction
Ca 2 ϩ is a versatile second messenger that mediates a wide range of cellular processes, including cell division and apoptosis (Berridge et al., 2003) . Under physiological conditions, cytoplasmic Ca 2 ϩ is maintained at a low level, and it is the elevation of cytoplasmic Ca 2 ϩ that generates Ca 2 ϩ signals. Elevated Ca 2 ϩ transmits information by activating Ca 2 ϩ -sensitive effectors, including phosphatases and kinases. The Ca 2 ϩ elevation involved in signal transduction is often in the form of repetitive Ca 2 ϩ spikes or oscillations (Berridge, 1997b) . The informationprocessing capability of Ca 2 ϩ signaling is enhanced by modulation of the frequency, amplitude, and spatial properties of Ca 2 ϩ elevations. This in part explains how a simple messenger such as Ca 2 ϩ can regulate diverse cellular processes. In T cells, Ca 2 ϩ signals mediate a variety of responses to T cell receptor (TCR) activation, including cell proliferation and apoptosis (Winslow et al., 2003 ; for reviews see Berridge, 1997a; Lewis, 2001 Lewis, , 2003 Randriamampita and Trautmann, 2004) . As in all nonexcitable cells, the T cell Ca 2 ϩ response begins with the release of Ca 2 ϩ from the ER through inositol 1,4,5-trisphosphate (InsP 3 )-dependent Ca 2 ϩ channels (InsP 3 receptors). The resulting cytoplasmic Ca 2 ϩ elevation is amplified by Ca 2 ϩ entry through Ca 2 ϩ -release-activated Ca 2 ϩ channels on the plasma membrane, producing either a transient Ca 2 ϩ elevation or Ca 2 ϩ oscillations (Donnadieu et al., 1992a,b; Hess et al., 1993;  for review see Lewis, 2001 ). The Ca 2 ϩ signal is then transduced through Ca 2 ϩ /calmodulin-mediated activation of the protein phosphatase calcineurin, which dephosphorylates and thereby activates the nuclear factor of activated T cells (NFAT; for review see Lewis, 2003; Winslow et al., 2003) . NFAT is a transcription factor that activates the interleukin-2 promoter, increasing cell proliferation. Activation of calcineurin, and hence NFAT, is sustained more efficiently by Ca 2 ϩ oscillations than by a transient elevation of Ca 2 ϩ , whereas other Ca 2 ϩ responses (e.g., nuclear factor kB and c-Jun NH 2 -terminal kinase activation) are preferentially activated by transient Ca 2 ϩ elevation (Dolmetsch et al., 1997 (Dolmetsch et al., , 1998 . The importance of Ca 2 ϩ oscillations in T cell signaling is increasingly recognized, including evidence that Ca 2 ϩ oscillations regulate thymocyte motility during positive selection in the thymus (Bhakta et al., 2005) .
We recently reported that the antiapoptotic protein Bcl-2 (Cory and Adams, 2002) interacts with InsP 3 receptors on the ER and inhibits InsP 3 -mediated Ca 2 ϩ efflux (Chen et al., 2004) . As a consequence, Bcl-2 dampens the cytoplasmic Ca 2 ϩ elevation induced by an antibody to the CD3 component of the TCR complex. These findings are intriguing in view of the known role of Ca 2 ϩ in signaling apoptosis (for reviews see Hajnoczky et al., 2003; Orrenius et al., 2003; Hanson et al., 2004) , but an inhibitory effect of Bcl-2 on InsP 3 -mediated Ca 2 ϩ elevation would seem incompatible with the wide range of physiological processes governed by InsP 3 -mediated Ca 2 ϩ signals. Would not Bcl-2 interfere with Ca 2 ϩ signals that regulate physiological processes required for cell function and survival?
A possible clue to this dilemma was provided by earlier work indicating that Ca 2 ϩ responses after TCR activation vary according to the strength of TCR activation (Donnadieu et al., 1992a) . Typically, strong signals induced by a high concentration of anti-CD3 antibody trigger a single transient elevation of cytoplasmic Ca 2 ϩ , whereas weaker signals induced by a low concentration of anti-CD3 induce Ca 2 ϩ oscillations (Donnadieu et al., 1992a) . Our previous experiments demonstrating an inhibitory effect of Bcl-2 on anti-CD3-induced Ca 2 ϩ elevation used a high concentration of anti-CD3 antibody that induced a transient Ca 2 ϩ elevation rather than Ca 2 ϩ oscillations. Therefore, in the present work, we investigated the effect of Bcl-2 on Ca 2 ϩ signals induced over a broad range of anti-CD3 concentrations. This led to the discovery that Bcl-2 differentially regulates Ca 2 ϩ signals according to the strength of TCR activation. Thus, Bcl-2 inhibited the transient Ca 2 ϩ elevation induced by a high concentration of anti-CD3 antibody, without interfering with Ca 2 ϩ oscillations induced by a low concentration of anti-CD3 antibody. Accordingly, Bcl-2 inhibited Ca 2 ϩ -mediated apoptosis after strong TCR activation but did not inhibit NFAT activation after weak TCR activation. Therefore, by selectively regulating Ca 2 ϩ signals according to the strength of TCR activation, Bcl-2 discriminates between proapoptotic and prosurvival Ca 2 ϩ signals.
Results

Bcl-2 inhibits Ca 2 ؉ elevation induced by high but not low anti-CD3 antibody
The WEHI7.2 T cell line corresponds to an immature doublepositive stage of T cell differentiation, as WEHI7.2 cells express both CD4 and -8 antigens and are sensitive to glucocorticosteroidinduced apoptosis. Consistent with this stage of development, Bcl-2 is virtually undetectable in WEHI7.2 cells. In earlier work, Bcl-2-positive and -negative clones were derived by stably transfecting WEHI7.2 cells with an expression vector encoding full-length human Bcl-2 or an empty vector, respectively. The full characterization of the clones used in this work has been reported previously (Chen et al., 2004) . All findings reported here are based on comparison of three Bcl-2-positive and three Bcl-2-negative clones. Findings were consistent The width of transient elevations induced by 20 g/ml anti-CD3 and both transient elevations and oscillatory spikes induced by 2 g/ml anti-CD3 were recorded. The width was measured at one third of the peak height. Data are from experiments 110804N2 (29 transient elevations) and 110504B17 (19 transient elevations) at 20 g/ml and experiments 110804N2 (119 elevations) and 110804B17 (66 elevations) at 2 g/ml anti-CD3. Data from three Bcl-2-negative clones (N2, -10, and -11) and three Bcl-2-positive clones (B6, -9, and -17) were in agreement and therefore were combined in B-D. Error bars represent mean Ϯ SEM. Asterisks designate a statistically significant difference (P Ͻ 0.01).
among the different clones; therefore, data from individual clones have been pooled, unless otherwise noted.
Throughout this paper, cytoplasmic Ca 2 ϩ was measured at a single-cell level by digital imaging. An initial series of Ca 2 ϩ measurements was performed to determine the doseresponse relationship between anti-CD3 concentration and cytoplasmic Ca 2 ϩ response patterns in a Bcl-2-negative clone (Fig. 1 A) . In this experiment, a transient elevation of Ca 2ϩ was defined as only one or two Ca 2ϩ elevations reaching at least twice the basal level of Ca 2ϩ , whereas sustained Ca 2ϩ oscillations were defined as three or more Ca 2ϩ spikes at least twice the basal level of Ca 2ϩ and separated by at least a 30-s interval. The percentage of cells responding with a transient Ca 2ϩ elevation was maximal at 20 g/ml anti-CD3 antibody and declined progressively with increasing antibody dilution (Fig. 1 A) . Conversely, the percentage of cells developing Ca 2ϩ oscillations increased progressively as anti-CD3 antibody concentration was reduced. Thus, there is a reciprocal dose-response relationship for transient elevations of Ca 2ϩ versus Ca 2ϩ oscillations after TCR activation. Based on these initial findings, subsequent studies used 20 g/ml as representative of a high concentration of anti-CD3 antibody and 2, 0.75, and 0.33 g/ml as representative of low concentrations of anti-CD3 antibody.
Representative Ca 2ϩ traces comparing Bcl-2-negative and -positive cells at a high anti-CD3 concentration (20 g/ml) are shown in Fig. 2 . Bcl-2-negative cells responded to high anti-CD3 with an almost synchronous elevation of cytoplasmic Ca 2ϩ as shown in Fig. 2 A, where multiple single-cell Ca 2ϩ traces collected in a single experiment (i.e., a single microscope coverslip) are plotted together. In contrast, only a small proportion of Bcl-2-positive cells responded with a detectable Ca 2ϩ elevation (Fig. 2 E) . The inhibitory effect of Bcl-2 on anti-CD3-induced Ca 2ϩ elevation in these experiments is also illustrated by averaging the Ca 2ϩ response of multiple cells (Fig. 2, B and F) . Characteristics of Ca 2ϩ responses at a singlecell level are illustrated by the Ca 2ϩ traces in Fig. 2 (C , D, G, and H) . Though the number of responding cells and the amplitude of Ca 2ϩ elevations differed markedly between Bcl-2-negative and -positive cells, the shape of the Ca 2ϩ elevation was similar. In a small percentage of cells, secondary Ca 2ϩ elevations were observed (e.g., Fig. 2 H) , but as noted in Fig. 1 B, sustained oscillations were infrequent.
Representative Ca 2ϩ traces comparing Bcl-2-negative and -positive cells at lower concentrations of anti-CD3 antibody (2, 0.75, and 0.33 g/ml) are shown in Fig. 3 . In contrast to the broad elevation of Ca 2ϩ triggered at 20 g/ml anti-CD3, the Ca 2ϩ responses at low concentrations of anti-CD3 antibody were typically in the form of narrow spikes. Also, in contrast to the inhibitory effect of Bcl-2 on Ca 2ϩ responses at high anti-CD3, Bcl-2 did not inhibit the Ca 2ϩ spikes evoked by low concentrations of anti-CD3. This is illustrated by the representative traces shown in Fig. 3 . In Fig. 3 , B-D and F-H show repetitive Ca 2ϩ spikes, or oscillations, detected in both Bcl-2-negative and -positive cells over the range of anti-CD3 concentrations tested, whereas A and E show cells where only one or two Ca 2ϩ spikes were detected. Note that the Ca 2ϩ oscillations induced by low anti-CD3 were irregular in terms of both amplitude and frequency. This is characteristic of Ca 2ϩ oscillations in T cells, as reported previously, and is in contrast to the more uniform pattern of Ca 2ϩ oscillations observed in nonlymphoid cells (for reviews see Lewis, 2001; Randriamampita and Trautmann, 2004) . Also, spontaneous Ca 2ϩ oscillations were not detected in control experiments where anti-CD3 was not added to cells.
The responses of cells to either high (20 g/ml) or low (2, 0.75, or 0.33 g/ml) anti-CD3 in a large number of experiments are summarized in Fig. 1 (B and C) . These data indicate that oscillations are much more frequent at the low than at the high concentration of anti-CD3 (Fig. 1 B) . Moreover, these data confirm that Bcl-2 markedly inhibits Ca 2ϩ responses to strong TCR activation (20 g/ml anti-CD3 antibody), based on a significant (P Յ 0.01) reduction in both the percentage of cells that respond ( Fig. 1 B) and the amplitude of Ca 2ϩ elevations in those cells that do respond (Fig. 1 C) . In contrast, Bcl-2 did not inhibit Ca 2ϩ responses to weak TCR activation (2, 0.75, or 0.33 g/ml anti-CD3 antibody), based on the percentage of cells that respond ( Fig. 1 B) and the mean amplitude of Ca 2ϩ spikes ( Fig.  1 C) . Interestingly, at low anti-CD3 in Bcl-2-positive cells, there was a small but insignificant (P Ͼ 0.10) reduction in the percentage of cells developing a transient Ca 2ϩ elevation (i.e., one or two Ca 2ϩ spikes; Fig. 1 B, left) and a small but insignificant (P Ͼ 0.10) increase in the percentage of cells developing sustained Ca 2ϩ oscillations (i.e., three or more Ca 2ϩ spikes; Fig.  1 B, right). Moreover, the mean amplitude of Ca 2ϩ spikes at the lowest anti-CD3 concentration (.33 g/ml) was higher in Bcl-2-positive than in Bcl-2-negative cells ( Fig. 1 C) , although this difference was not statistically significant (P Ͼ 0.10).
As noted in Fig Overall, the frequency of Ca 2ϩ oscillations induced by 2 g/ml anti-CD3 antibody appeared higher in Bcl-2-positive than in Bcl-2-negative cells, although differences reached statistical significance only during the 15-min time interval (P ϭ 0.01) and borderline significance during the 10-min time interval (P ϭ 0.057; Fig. 4 A) . The frequency of oscillations also appeared to be higher in Bcl-2-positive cells at 0.75 g/ml anti-CD3 antibody, but differences were not statistically significant at any of the time intervals (Fig. 4 B) . To analyze oscillatory frequency by a different method, the time interval between Ca 2ϩ spikes was measured in multiple Ca 2ϩ traces at 2 g/ml anti-CD3 antibody and, based on these data, mean and mode frequencies were calculated. The mean frequency of Ca 2ϩ oscillations in Bcl-2-negative cells was 5.2 Ϯ 0.6 mHz, whereas the mode frequency was 7.3 Ϯ 0.55 mHz. Mean frequency was lower than mode frequency because of the presence of low-frequency spiking detected in a small proportion of the Ca 2ϩ traces. The mean frequency was not significantly different in Bcl-2-negative and -positive cells (Fig. 4 C) , but the mode frequency was significantly higher in Bcl-2-positive cells (Fig.  4 D) . Thus, consistent with the analysis in Fig. 4 A, this analysis suggests an increased frequency of Ca 2ϩ oscillations in Bcl-2-positive compared to Bcl-2-negative cells. The total duration of Ca 2ϩ oscillatory runs (i.e., time duration from initial to final Ca 2ϩ spikes) appeared longer in Bcl-2-positive than in Bcl-2-negative cells, although this difference was of borderline significance (P ϭ 0.05; Fig. 4 E) . WEHI7.2 cells adhered loosely to coverslips, limiting the rate at which anti-CD3 antibody could be perfused onto cells. Therefore, to estimate latency period, the initial Ca 2ϩ response to 2 g/ml anti-CD3 antibody was recorded in cell suspensions fluorometrically (Fig. 4 F) . Based on these data, the latency period was on the order of 2 min and was the same in Bcl-2-negative and -positive cells. Although the preceding analyses suggest that Bcl-2 may slightly increase the frequency and duration of Ca 2ϩ oscillations, the major conclusion from these data is that Bcl-2 does not inhibit Ca 2ϩ oscillations induced by low concentrations of anti-CD3 antibody. Consistent with this finding, Bcl-2 did not inhibit NFAT activation (Fig. 4 G) .
Bcl-2 inhibits anti-CD3-induced apoptosis by inhibiting anti-CD3-induced
Ca
2؉ elevation
The mean amplitudes of Ca 2ϩ elevations induced by high and low concentrations of anti-CD3 antibody were compared in Fig. 1 C. Although the mean peak amplitude of the Ca 2ϩ elevation induced by 20 g/ml anti-CD3 was similar to the mean peak amplitude of Ca 2ϩ spikes induced by 2 g/ml anti-CD3, the net effect of amplitude and width of Ca 2ϩ peak is a much more substantial Ca 2ϩ elevation after high anti-CD3 than after low anti-CD3. Furthermore, analysis of the peak Ca 2ϩ elevation induced by 20 g/ml anti-CD3 on an individual cell basis illustrates a broad range of Ca 2ϩ elevations detected in Bcl-2-negative cells (Fig. 5) . 27% of the Ca 2ϩ spikes in Bcl-2-negative cells were Ͼ200 nM, an arbitrarily chosen threshold level, whereas only 7% of Ca 2ϩ spikes in Bcl-2-positive cells were higher than this level after treatment with 20 g/ml anti-CD3 antibody. Therefore, Bcl-2 not only reduces the percentage of cells that elevate Ca 2ϩ in response to high anti-CD3 (Fig. 1 B) but also dampens Ca 2ϩ elevations in the cells was continuously monitored by digital imaging in Bcl-2-negative and -positive cells before and after addition of 2 g/ml anti-CD3 antibody. Ca 2ϩ traces were divided into successive 5-min intervals, and the number of Ca 2ϩ spikes per cell in each 5-min interval was recorded as a measure of oscillatory frequency. The analysis was performed on 25 coverslips of Bcl-2-negative cells and 33 coverslips of Bcl-2-positive cells. The frequency of Ca 2ϩ spike activity appeared higher in Bcl-2-positive cells at all but the 40-min time period, but the difference between Bcl-2-negative and -positive cells was significant only during the 15-min time period (*, P ϭ 0.01) and borderline significant during the 10-min time period (**, P ϭ 0.057). (B) The same method of analysis was performed on Ca 2ϩ traces at 0.75 g/ml anti-CD3 antibody, although fewer experiments were performed at this antibody concentration (six coverslips of Bcl-2-negative cells and five coverslips of Bcl-2-positive cells). None of the apparent differences between oscillatory frequency in Bcl-2-negative and -positive cells were statistically significant (P Ͼ 0.10). (C) The time period between the peaks of individual Ca 2ϩ spikes induced by 2 g/ml anti-CD3 antibody was measured and used to calculate the mean frequency of Ca 2ϩ oscillations. The difference between Bcl-2-negative and -positive cells was not significant (P Ͼ 0.10). (D) The mode frequency of Ca 2ϩ oscillations induced by 2 g/ml anti-CD3 was calculated from the data in C. The mode frequency of oscillations in Bcl-2-positive cells was higher than that in Bcl-2-negative cells (*, P ϭ 0.01). (E) The duration of oscillations induced by 2 g/ml anti-CD3 antibody was measured as the time between the initial and the final Ca 2ϩ elevations in an oscillatory run. The apparent difference between the duration of oscillations in Bcl-2-negative and -positive cells was not significant (P Ͼ 0.10). Error bars represent mean Ϯ SEM. In F and G, suspensions of Bcl-2-negative and -positive cells were treated with 2 g/ml anti-CD3 antibody. that do respond by preventing very high peak Ca 2ϩ elevations. In contrast to the wide distribution of Ca 2ϩ elevations observed at 20 g/ml anti-CD3 antibody in Bcl-2-negative cells, only 6 and 1% of Ca 2ϩ spikes were Ͼ200 nM at 2 and 0.75 g/ml anti-CD3 antibody in Bcl-2-negative cells (Fig. 5) . Even fewer cells elevated their Ca 2ϩ to Ͼ200 nM at these low concentrations of anti-CD3 antibody in Bcl-2-positive cells (Fig. 5 C) . Thus, although Bcl-2 did not reduce the percentage of cells that responded to low concentrations of anti-CD3 antibody by developing sustained Ca 2ϩ oscillations (Fig. 1 B) and did not reduce the mean amplitude of these Ca 2ϩ elevations (Fig. 1 C) , it does appear to have set a threshold level above which the Ca 2ϩ does not elevate even in response to weak TCR activation.
To investigate the contribution of high Ca 2ϩ elevations to anti-CD3-induced apoptosis, cells were treated with 20 g/ml anti-CD3 antibody and sorted by flow cytometry into two different populations based on relative levels of cytoplasmic Ca 2ϩ (Fig. 6 A) . The cells were then placed in culture, and the percentage of apoptotic cells was measured 24 h later. A significantly higher percentage of cells in the high Ca 2ϩ population underwent apoptosis, compared to cells in the low Ca 2ϩ population (Fig.  6 B) . Conversely, reducing extracellular Ca 2ϩ concentration, a condition that partially prevents Ca 2ϩ elevation after treatment with high anti-CD3 (Fig. 7 A) , inhibited apoptosis (Fig. 7 B) . Thus, the induction of apoptosis in Bcl-2-negative cells is Ca 2ϩ dependent, and the percentage of cells undergoing apoptosis is proportional to the peak amplitude of Ca 2ϩ elevation after treatment with a high concentration of anti-CD3 antibody. Consistent with these findings, Bcl-2 inhibited apoptosis induction by high anti-CD3 (Fig. 7, C and D) , in accordance with the dampening effect of Bcl-2 on anti-CD3-induced Ca 2ϩ elevation described in preceding experiments (Fig. 5) . Treatment with low anti-CD3 did not induce apoptosis (Fig. 7 C) , consistent with the evidence that high Ca 2ϩ elevation (Ն200 nM) was much less common after treatment with low anti-CD3 than it was after treatment with high anti-CD3 (Fig. 5) . Interestingly, the percentage of apoptotic cells was lower after treatment with low anti-CD3 antibody than it was in untreated cells (Fig. 7 C) . This suggests that treatment with low anti-CD3 may have a prosurvival action, in contrast to the proapoptotic action of high anti-CD3. Ca 2ϩ elevations to Ͻ40 nM were not recorded. Data are from multiple experiments (150 elevations for Bcl-2-negative cells at 20 g/ml; 58 transient elevations for Bcl-2-positive cells at 20 g/ml; 758 spikes for Bcl-2-negative cells at 2 g/ml; 1,430 spikes for Bcl-2-positive cells at 2 g/ml; 559 spikes for Bcl-2-negative cells at 0.75 g/ml; 692 spikes for Bcl-2-positive cells at 0.75 g/ml). 
Effect of InsP 3 receptor knockdown on
Ca
2؉ responses to strong and weak
TCR activation
To address the question of how Bcl-2 differentially regulates Ca 2ϩ signals induced by high versus low concentrations of anti-CD3 antibody, we used small interfering RNA (siRNA) to reduce levels of all three InsP 3 receptor subtypes in WEHI7.2 cells (Fig. 8) . The siRNA olignucleotide pools were introduced into cells by electroporation with a transfection efficiency of 78 Ϯ 2% (mean Ϯ SEM). The siRNA-mediated reduction in InsP 3 receptor levels was documented by Western blotting (Fig. 8 A) . Substantial reduction in all three InsP 3 receptor subtypes was reproducibly achieved (Fig. 8 B) . This reduction in InsP 3 receptors significantly inhibited the Ca 2ϩ elevation induced by 20 g/ml anti-CD3 antibody (Fig. 8, C and D) . But the siRNAmediated reduction in InsP 3 receptor levels did not inhibit Ca 2ϩ responses to 2 g/ml anti-CD3 antibody. This is documented by representative Ca 2ϩ traces (Fig. 8, E and F) , by analysis of the percentage of responding cells (Fig. 8 G) , and by amplitude analysis (Fig. 8 H) . Thus, consistent with the inhibitory effect of Bcl-2 on Ca 2ϩ responses to strong but not to weak TCR activation, the former appears to be more dependent on InsP 3 receptor expression levels than the latter.
Discussion
The principal finding in this study is that Bcl-2 differentially regulates Ca 2ϩ signaling in T cells according to the strength of TCR activation. Bcl-2 was found to inhibit the cytoplasmic Ca 2ϩ elevation induced by a high concentration of anti-CD3
antibody but did not inhibit Ca 2ϩ elevation induced by low concentrations of anti-CD3 antibody. This finding evolved as a natural extension of our earlier investigation into the effect of Bcl-2 on InsP 3 receptor-mediated Ca 2ϩ release from the ER (Chen et al., 2004) . Those studies initially used fluorometric measurements of Ca 2ϩ elevation in response to a relatively high concentration of anti-CD3 antibody. It was this Ca 2ϩ elevation that we found to be inhibited by Bcl-2. Although digital imaging was eventually used in addition to fluorometry in these earlier studies, a high concentration of anti-CD3 antibody was adhered to throughout. Thus, only the effect of Bcl-2 on the transient Ca 2ϩ elevation induced by a relatively high concentration of anti-CD3 antibody was investigated. The present study was undertaken based on the prediction that Ca 2ϩ oscillations would be detected if a lower concentration of anti-CD3 antibody were used. This prediction was based on evidence that high concentrations of cell surface receptor agonists generally induce transient elevations of Ca 2ϩ , whereas low concentrations of agonist are more likely to induce sustained oscillations (Berridge, 1990) . Consistent with this paradigm, it was previously reported that strong TCR activation induces primarily a transient Ca 2ϩ elevation, whereas weaker TCR activation induces primarily repetitive Ca 2ϩ spikes, or oscillations (Donnadieu et al., 1992a) .
As anticipated, the Ca 2ϩ response pattern in WEHI7.2 cells underwent a transition from transient Ca 2ϩ elevation to sustained oscillations as anti-CD3 antibody concentration was decreased (Fig. 1 A) . The Ca 2ϩ oscillations induced by anti-CD3 antibody were irregular in their amplitude and frequency (Fig. 3) . This is characteristic of Ca 2ϩ oscillations in T cells, 2ϩ inhibits anti-CD3-induced apoptosis. Apoptosis was quantified according to nuclear morphological changes as in Fig. 6 , 24 h after adding 20 g/ml anti-CD3 to Bcl-2-negative cells suspended in regular DME (ϩ), which contains 1.3 mM of extracellular Ca 2ϩ , or nominally Ca 2ϩ -free DME (Ϫ). Anti-IgG antibody was added 30 min after anti-CD3 antibody. Error bars represent mean Ϯ SEM in three experiments. The asterisk denotes the significant (P Ͻ 0.01) inhibitory effect of low extracellular Ca 2ϩ on apoptosis induction. (C) In Bcl-2-negative cells, apoptosis is induced by 20 g/ml anti-CD3 antibody but not by 2 g/ml anti-CD3 antibody. Bcl-2 inhibits apoptosis induction by anti-CD3 antibody. The percentage of apoptotic cells was determined by epifluorescence microscopy 24 h after adding either 20 or 2 g/ml anti-CD3 antibody. Anti-IgG antibody was added 30 min after anti-CD3 antibody. Error bars represent mean Ϯ SEM of multiple experiments. The asterisk denotes the significant (P Ͻ 0.01) inhibitory effect of Bcl-2 on apoptosis induction by 20 g/ml anti-CD3 antibody. as reported previously by others, and is in contrast to the more uniform pattern of Ca 2ϩ oscillations observed in nonlymphoid cells (for reviews see Lewis, 2001; Randriamampita and Trautmann, 2004) . The irregularity of anti-CD3-induced Ca 2ϩ oscillations necessitated a large number of experiments to objectively compare oscillatory responses in Bcl-2-negative and -positive cells (Fig. 4) . The only significant differences were an increase in oscillatory frequency (Fig. 4 , A and D) and duration of oscillations (Fig. 4 E) in Bcl-2-positive cells. The oscillatory patterns induced in Bcl-2-negative and -positive cells were indistinguishable in all other respects, including the percentage of cells that developed oscillations (Fig. 1 B) , amplitude ( Fig. 1 C) , width of Ca 2ϩ spikes (Fig. 1 D) , and latency period (Fig. 4 F) . It has been reported that NFAT is optimally activated by Ca 2ϩ oscillations (Dolmetsch et al., 1998; Tomida et al., 2003 ; for reviews see Lewis, 2003; Winslow and Crabtree, 2005) . Therefore, NFAT activation was measured as a convenient "readout" of the Ca 2ϩ oscillations induced by anti-CD3 in WEHI7.2 cells.
Consistent with the finding that Bcl-2 did not inhibit anti-CD3-induced Ca 2ϩ oscillations, Bcl-2 did not inhibit NFAT activation (Fig. 4 G) .
The finding that Bcl-2 selectively inhibits the transient Ca 2ϩ elevation induced by high anti-CD3 without interfering with Ca 2ϩ oscillations induced by low anti-CD3 is relevant to the role of Bcl-2 in regulating apoptosis, as WEHI7.2 cells undergo apoptosis after treatment with high anti-CD3 but not when treated with low anti-CD3 (Fig. 7 C) . Moreover, apoptosis induction by high anti-CD3 was Ca 2ϩ mediated (Fig. 7, A  and B) , and the percentage of cells undergoing apoptosis was proportional to the level of Ca 2ϩ elevation (Fig. 6 ). These findings are consistent with evidence that apoptosis induction after TCR activation is triggered by InsP 3 receptor-mediated Ca 2ϩ elevation (Nakayama et al., 1992; Jayaraman and Marks, 1997) . Thus, by selectively repressing the Ca 2ϩ elevation induced by strong TCR activation, Bcl-2 inhibits apoptosis without interfering with physiological Ca 2ϩ signals induced by weak TCR activation. The present findings are intriguing in light of the known role of Bcl-2 in T cell development. T cells located in the thymic cortex are TCR positive and both CD4ϩ and CD8ϩ ("double positive"). At this stage of T cell development, Bcl-2 expression is low and cortical thymocytes are highly susceptible to apoptosis induction after TCR activation by antigen or anti-CD3 antibody (Smith et al., 1989; Murphy et al., 1990; Shi et al., 1991; Nakayama et al., 1992) . When T cells mature and migrate to the thymic medulla, they remain TCR positive but become either CD4ϩCD8Ϫ or CD4ϪCD8ϩ ("single positive"). Bcl-2 expression is increased at this stage of development, and as a consequence, single-positive thymocytes are less susceptible to apoptosis than are cortical thymocytes (Gratiot-Deans et al., 1993; Veis et al., 1993) . A strong correlation has been demonstrated between Bcl-2 expression and susceptibility to Ca 2ϩ -induced apoptosis during T cell development (Andjelic et al., 1993) . Thymocytes at the earliest stage of development (TCRϪCD4ϪCD8Ϫ), the stage during which thymocytes relocate from bone marrow to thymus, express high levels of Bcl-2 and are resistant to Ca 2ϩ -mediated apoptosis, whereas thymocytes in the next stage of development (TCRϩCD4ϩCD8ϩ) are highly susceptible to Ca 2ϩ -mediated apoptosis. It is in this stage of development that thymocytes undergo either negative or positive selection. Strong ligation of the TCR (e.g., by selfpeptide-major histocompatibility complex [MHC] complexes) induces negative selection, whereas weak ligation of the TCR (e.g., by foreign antigen-MHC complexes) induces positive selection (for review see Hogquist, 2001; Neilson et al., 2004) . Double-positive thymocytes from Bcl-2-transgenic mice accumulate excessively because of reduced negative selection and are resistant to anti-CD3-induced apoptosis (for review see Cory, 1995) . Therefore, the role of Bcl-2 expression during T cell development may be to regulate when and where negative selection occurs. Decreased Bcl-2 expression in double-positive cortical thymocytes, but not in earlier or later stages of T cell development, may limit negative selection to the cortical region of the thymus and to this stage of development. Elevated Bcl-2 expression at earlier (double negative) and later (single positive) stages of T cell development may dampen Ca 2ϩ transients produced by strong TCR engagement while permitting repetitive Ca 2ϩ oscillations that signal cell proliferation and survival. The mechanism by which Bcl-2 differentially regulates Ca 2ϩ elevation after strong but not weak TCR activation is not entirely understood. In our earlier work (Chen et al., 2004) , the inhibitory effect of Bcl-2 on anti-CD3-induced Ca 2ϩ elevation appeared to be mediated at the level of the InsP 3 receptor rather than in upstream TCR signaling pathways. This conclusion was based on two experimental strategies in which upstream TCR signaling pathways were bypassed. In one strategy, we found that Bcl-2 inhibited Ca 2ϩ elevation induced by a cell-permeant InsP 3 ester. In the other strategy, we found that Bcl-2 inhibited ER Ca 2ϩ release induced by adding InsP 3 to cells in which the plasma membrane had been permeabilized by digitonin. In addition, Bcl-2 appeared to interact with InsP 3 receptors, based on results of blue native gel electrophoresis and coimmunoprecipitation (Chen et al., 2004) . Finally, purified Bcl-2 inhibited InsP 3 -gated single-channel opening when microsomal membrane fractions containing InsP 3 receptors were incorporated into planar lipid bilayers (Chen et al., 2004) . Therefore, the collective evidence that Bcl-2 interacts with InsP 3 receptors and inhibits InsP 3 -mediated Ca 2ϩ release from the ER raises the question of whether the induction of Ca 2ϩ oscillations by low concentrations of anti-CD3 antibody is InsP 3 receptor independent or at least requires far fewer functional InsP 3 receptors than does the elevation of Ca 2ϩ induced by a high concentration of anti-CD3 antibody.
To address this question, we used siRNA to reduce InsP 3 receptor levels in WEHI7.2 cells (Fig. 8) . This procedure inhibited Ca 2ϩ elevation induced by strong TCR activation but did not inhibit the induction of Ca 2ϩ oscillations by weak TCR activation. In contrast, Ca 2ϩ responses evoked in HeLa cells by both high and low concentrations of ATP or histamine were repressed by InsP 3 receptor type 1 knockdown (Hattori et al., 2004) . Thus, mechanisms of Ca 2ϩ oscillation formation after TCR activation and G protein-coupled receptor activation may differ. Our findings indicate that Ca 2ϩ responses initiated by weak TCR activation are generated independent of InsP 3 receptor-mediated Ca 2ϩ release or that only a relatively small proportion of the full InsP 3 receptor complement is required to initiate Ca 2ϩ signals in response to weak TCR activation.
In future studies, the mechanism of how Bcl-2 regulates InsP 3 receptor function will be addressed in greater depth. In preliminary studies, we found that Bcl-2 overexpression decreases InsP 3 receptor phosphorylation in WEHI7.2 cells. Moreover, it has recently been reported that Bcl-2 interacts with InsP 3 receptors in a manner that is dependent on the Bcl-2 phosphorylation state and may regulate Ca 2ϩ dynamics in the ER through regulation of InsP 3 receptor phosphorylation (Bassik et al., 2004; Oakes et al., 2005) . Others have reported that in neuronal cells Bcl-2 shuttles calcineurin to InsP 3 receptors and regulates Ca 2ϩ release from internal stores (Erin et al., 2003a,b; Erin and Billingsley, 2004) . Therefore, one hypothesis is that strong TCR signals enhance InsP 3 receptor phosphorylation, enhancing InsP 3 -induced Ca 2ϩ release, and that Bcl-2 dampens the Ca 2ϩ response to strong TCR activation by mediating dephosphorylation of InsP 3 receptors. Although untested, this theory is consistent with evidence that phosphorylation regulates the Ca 2ϩ channel activity of InsP 3 receptors (Cameron et al., 1995; Jayaraman et al., 1996; deSouza et al., 2002; Straub et al., 2002; Cui et al., 2004) .
In summary, we previously discovered that the known antiapoptotic protein Bcl-2 interacts with InsP 3 receptors and inhibits InsP 3 -induced Ca 2ϩ release from the ER in T cells. In this paper, we report that Bcl-2 selectively inhibits Ca 2ϩ elevation induced by high but not low anti-CD3. As a consequence, Bcl-2 represses the transient elevation of Ca 2ϩ associated with apoptosis induction after strong TCR activation but does not interfere with Ca 2ϩ oscillations that activate NFAT after weak TCR activation. The capacity of Bcl-2 to differentially regulate Ca 2ϩ signals induced by strong versus weak TCR activation allows Bcl-2 to selectively inhibit apoptotic Ca 2ϩ signals without interfering with Ca 2ϩ signals that mediate cell proliferation and survival.
Materials and methods
Reagents
EGTA and standard reagents were purchased from Sigma-Aldrich. Fura-2-AM and Hoechst 33342 were purchased from Invitrogen. Hamster anti-mouse CD3e chain monoclonal antibody (clone 145-2C11) and mouse anti-hamster IgG1 monoclonal antibody were obtained from BD Biosciences. Mouse monoclonal antibody NFATc2 was obtained from Santa Cruz Biotechnology, Inc.
Cell culture WEHI7.2 cells were cultured in DME supplemented with 10% bovine calf serum, 2 mM L-glutamine, and 100 M of nonessential amino acids. Transfection procedures, isolation of Bcl-2-positive and -negative clones, and the characterization of these clones were reported previously (Chen et al., 2004) .
Ca
2ϩ imaging Methods of Ca 2ϩ imaging, described in detail previously (Chen et al., 2004) , were used here with only minor modifications. In brief, cells adhered to poly-L-lysine-coated coverslips (35-mm coverslip dishes; MatTek Corp.) were loaded with 1 M fura-2-AM for 45 min at 25ЊC in extracellular buffer (ECB; 130 mM NaCl, 5 mM KCl, 1.5 mM CaCl 2 , 1 mM MgCl 2 , 25 mM Hepes, pH 7.5, 1 mg/ml BSA, and 5 mM glucose). The buffer was replaced with fresh ECB and the incubation was continued for 45 min at 25ЊC to permit deesterification. Culture dishes were mounted on the nonheated stage of an inverted microscope (CKX41; Olympus) equipped with a 20ϫ fluor objective. Excitation light was alternated between 340 and 380 nm by a filter wheel (Sutter Instrument Co.), with 0.8-and 0.2-s exposure times, respectively, and emitted light was filtered at Ͼ510 nm and collected with an intensified charge-coupled device camera (12-bit VGA; Cooke). Anti-CD3 antibody was gently added to buffer overlaying the coverslip so as not to disturb cells loosely adherent to the coverslip. The video signal was digitized using InCyt Im2 software (Intracellular Imaging) and subsequently processed using Excel (Microsoft). To determine R min , cells were perfused with ECB deficient in Ca 2ϩ and supplemented with 4 mM EGTA and 10 M ionomycin. R max was obtained by perfusing cells with ECB supplemented with 4 mM CaCl 2 and 10 M ionomycin. Ca 2ϩ concentration was calculated based on the published K d for fura-2 of 220 nM, by the equation of Grynkiewicz et al. (1985) .
Fluorometric Ca
2ϩ measurements The measurement of Ca 2ϩ concentration in cell suspensions by fluorometry using fura-2-AM have been described in detail previously (Chen et al., 2004) .
NFAT Westerns
Cells were treated with 2 g/ml anti-CD3 antibody for various time periods at ambient temperature, after which they were placed on ice, pelleted, and resuspended in RIPA buffer (1% Triton X-100, 0.1% SDS, 50 mM Tris, pH 7.6, 150 mM NaCl, and 200 mM DTT) supplemented with Complete mini protease inhibitors (Roche) and Phosphatase inhibitor cocktails I and II (Sigma-Aldrich). Cell extracts were resolved by electrophoresis on 7% SDS-polyacrylamide gels under reducing conditions. The separated proteins were transferred to Immobilon-P PVDF membranes (Millipore) and incubated with anti-NFATc2 antibody at a dilution of 1:500, followed by incubation with horseradish peroxidase-conjugated goat antimouse IgG and visualized by the ECL Western blotting detection reagent (GE Healthcare).
InsP 3 receptor Westerns
Western analysis for InsP 3 receptors was performed as described previously (Chen et al., 2004) . Protein samples were extracted as in the preceding method and resolved (60 g/lane) through 4-20% gradient gels (Bio-Rad Laboratories). The antibodies for types 1 and 3 InsP 3 receptors were purchased from EMD Biosciences and BD Biosciences, respectively. The antibody for type 2 InsP 3 receptor was a gift from R. Wojcikiewicz (State University of New York Upstate Medical University, Syracuse, NY). The antibody for actin was obtained from Sigma-Aldrich. Secondary antibodies were obtained from GE Healthcare.
Apoptosis assay
Cells were stained with Hoechst 33342 (final concentration 10 g/ml), and typical apoptotic nuclear morphology was detected by epifluorescence microscopy using a microscope (Axiovert S100; Carl Zeiss MicroImaging, Inc.) equipped with a 63ϫ oil/1.4 NA plan apochromat objective (Carl Zeiss MicroImaging, Inc.) and a filter cube (model XF23; Omega Optical; excitation ϭ 485 nm, emission ϭ 535 nm). Images were taken on a charge-coupled device camera (ORCA C4742-95-cooled; Hamamatsu) operating with Simple PCI software (Compix, Inc.).
Flow cytometry
Cells (1 million/ml) were loaded with 5 M calcium green-AM (Invitrogen) for 45 min at 37ЊC in ECB. The cells were then pelleted and resuspended in ECB at the same concentration and incubated at room temperature for 30 min to allow dye deesterification. The cells were then pelleted and concentrated to 5 million/ml. The cells were then analyzed and sorted on a flow cytometer (Epics Elite; Beckman Coulter). Calcium green fluorescence was measured after dye excitation with a 488-nM argon laser, and emitted light collection was measured through a 525-nM band-pass filter. The cells were initially run through the flow cytometer for 1 min to assess basal cytosolic Ca 2ϩ , and 20 g/ml anti-CD3 antibody was then added. The cells were gated and sorted into two populations: cells with a high level of Ca 2ϩ elevation and cells with a low level of Ca 2ϩ elevation. The sorted cells were pelleted and resuspended in fresh culture medium and 20 g/ml anti-CD3 antibody was re-added, and 30 min later an equal concentration of anti-hamster IgG was added. Apoptosis was measured 24 h later, as described in the previous section.
RNA interference
The negative control, siCONTROL Non-Targeting siRNA Pool, and siGE-NOME SMARTpools for all three subtypes of InsP 3 receptor were purchased from Dharmacon. After suspension in 1ϫ siRNA buffer, SMARTpools were added at a concentration of 1 M each to 0.2-cm cuvettes containing 5 million WEHI7.2 cells suspended in 200 l Opti-MEM I (Invitrogen). Cuvettes were then subjected to a single 140V 10-ms 2 -wave pulse from a GenePulser Xcell (Bio-Rad Laboratories), and the contents of the cuvette were immediately added to fresh media. Cells were grown in culture after transfection for 48 h before use in experiments. Transfection efficiency was measured by transfecting siGLO Cyclophilin (Dharmacon) at a concentration of 1 M. After 30 min, cells were pelleted and then resuspended in phosphate-buffered saline. Cells were visualized by fluorescence microscopy, with excitation at 546 nm, and at least 200 cells were counted in three separate experiments to determine the percentage of transfected cells.
Statistical analysis
Comparisons were made using the two-tailed t test for two samples, assuming equal variance.
